Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alba Vilajeliu, Víctor-Guillermo Sequera, Alberto L. García-Basteiro, Elisa Sicuri, Marta Aldea, César Velasco & José M. Bayas. (2016) Immunogenicity and immunization costs of adjuvanted versus non-adjuvanted hepatitis B vaccine in chronic kidney disease patients. Human Vaccines & Immunotherapeutics 12:9, pages 2317-2321.
Read now
Read now
Alicja E Grzegorzewska. (2015) Prophylactic vaccinations in chronic kidney disease: Current status. Human Vaccines & Immunotherapeutics 11:11, pages 2599-2605.
Read now
Read now
Alicja E Grzegorzewska. (2014) Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines. Expert Review of Vaccines 13:11, pages 1317-1326.
Read now
Read now
Christopher B Fox & Jean Haensler. (2013) An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Review of Vaccines 12:7, pages 747-758.
Read now
Read now
Articles from other publishers (9)
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit & Ezequiel Ridruejo. (2021) Hepatitis B virus vaccine and chronic kidney disease. The advances. Nefrología 41:2, pages 115-122.
Crossref
Crossref
Fabrizio Fabrizi, Roberta Cerutti, Rebeca Garcia-Agudo, Cecilia Bellincioni, Giulia Porata, Giulia Frontini, Sami Aoufi-Rabih & Piergiorgio Messa. (2020) Adjuvanted recombinant HBV vaccine (HBV-AS04) is effective over extended follow-up in dialysis population. An open-label non randomized trial. Clinics and Research in Hepatology and Gastroenterology 44:6, pages 905-912.
Crossref
Crossref
Darrick Carter, Malcolm S. Duthie & Steven G. Reed. 2020. Vaccination Strategies Against Highly Variable Pathogens. Vaccination Strategies Against Highly Variable Pathogens
103
127
.
Karen A.O. Martins, Christopher L. Cooper, Sabrina M. Stronsky, Sarah L.W. Norris, Steven A. Kwilas, Jesse T. Steffens, Jacqueline G. Benko, Sean A. van Tongeren & Sina Bavari. (2016) Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity. EBioMedicine 3, pages 67-78.
Crossref
Crossref
Fabrizio Fabrizi, Paul Martin & Piergiorgio Messa. (2016) Novel Perspectives on the Hepatitis B Virus Vaccine in the Chronic Kidney Disease Population. The International Journal of Artificial Organs 38:12, pages 625-631.
Crossref
Crossref
Ruchi R. Shah, Luis A. Brito, Derek T. O’Hagan & Mansoor M. Amiji. 2015. Subunit Vaccine Delivery. Subunit Vaccine Delivery
59
76
.
Mark R. Schleiss, K. Yeon Choi, Jodi Anderson, Janine Gessner Mash, Martine Wettendorff, Sally Mossman & Marc Van Damme. (2014) Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model. Vaccine 32:23, pages 2756-2762.
Crossref
Crossref
Theodoros Eleftheriadis. (2014) Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients. World Journal of Gastroenterology 20:34, pages 12018.
Crossref
Crossref
Alicja E. Grzegorzewska. (2012) Hepatitis B Vaccination in Chronic Kidney Disease: Review of Evidence in Non-Dialyzed Patients. Hepatitis Monthly 12:11.
Crossref
Crossref